Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 502

1.

Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ.

N Engl J Med. 2005 Mar 10;352(10):969-77.

2.

Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.

Agnelli G, Piovella F, Buoncristiani P, Severi P, Pini M, D'Angelo A, Beltrametti C, Damiani M, Andrioli GC, Pugliese R, Iorio A, Brambilla G.

N Engl J Med. 1998 Jul 9;339(2):80-5.

3.
4.

Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review.

Rahim SA, Panju A, Pai M, Ginsberg J.

Thromb Res. 2003;111(4-5):215-9.

PMID:
14693166
5.

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G.

N Engl J Med. 1998 Feb 12;338(7):409-15.

6.

Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.

Ugaki H, Enomoto T, Fujiwara K, Kimura T, Kawasaki T.

Blood Coagul Fibrinolysis. 2008 Sep;19(6):585-9. doi: 10.1097/MBC.0b013e32830708ad.

PMID:
18685443
7.

Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients.

Lecumberri R, Marqués M, Díaz-Navarlaz MT, Panizo E, Toledo J, García-Mouriz A, Páramo JA.

Thromb Haemost. 2008 Oct;100(4):699-704.

PMID:
18841295
8.
9.

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N.

N Engl J Med. 1999 Sep 9;341(11):793-800.

10.
11.

Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).

Haas S, Breyer HG, Bacher HP, Fareed J, Misselwitz F, Victor N, Weber J; ECHOS Trial Group.

Int Angiol. 2006 Dec;25(4):335-42.

PMID:
17164738
12.

Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study.

Baroletti S, Munz K, Sonis J, Fanikos J, Fiumara K, Paterno M, Goldhaber SZ.

J Thromb Thrombolysis. 2008 Apr;25(2):146-50. Epub 2007 Nov 17.

PMID:
18026689
13.

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.

Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV; CORTES Investigators. Clivarin: Assessment of Regression of Thrombosis, Efficacy, and Safety.

N Engl J Med. 2001 Mar 1;344(9):626-31.

15.

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators.

N Engl J Med. 2003 Jul 10;349(2):146-53.

17.

Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial.

Maxwell GL, Synan I, Dodge R, Carroll B, Clarke-Pearson DL.

Obstet Gynecol. 2001 Dec;98(6):989-95.

PMID:
11755543
18.
19.

DVT and pulmonary embolism: Part II. Treatment and prevention.

Ramzi DW, Leeper KV.

Am Fam Physician. 2004 Jun 15;69(12):2841-8. Review.

20.

Dalteparin versus unfractionated heparin in critically ill patients.

PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, Vallance S, Qushmaq I, Rocha M, Berwanger O, Vlahakis NE.

N Engl J Med. 2011 Apr 7;364(14):1305-14. doi: 10.1056/NEJMoa1014475. Epub 2011 Mar 22.

Supplemental Content

Support Center